BLAST Therapeutics Inc. is a specialty, development stage biomaterials company focused on developing materials that accelerate bone repair and regeneration to improve patient care. The technology, developed at The Institute for Regenerative Medicine at Texas A&M Health Science Center provides a platform technology based on the identification and characterization of two classes of bone marrow stem cells, as well as unique methods to condition these cells to increase their propensity for making bone.
